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whereas the expression of several other cystic genes did not 
change. More importantly,  Pkd1 haploinsufficiency acceler-
ated the development of tubular dilations after nephron re-
duction, a phenotype that was associated to a further in-
crease of cell proliferation. These data were relevant to hu-
mans ACKD, as cystic genes expression and the rate of cell 
proliferation were also increased. In conclusion, our study 
suggests that the nephron reduction can be considered a 
suitable model to study ACKD and that dosage of genes in-
volved in PKD is also important in ACKD. 
 © 2014 S. Karger AG, Basel 
 Introduction 
 Cystic kidney diseases are characterized by the pro-
gressive development of multiple fluid-filled cysts in re-
nal parenchyma leading to end-stage renal disease. Cystic 
kidney diseases may arise sporadically, be acquired, or 
inherited. Acquired cystic kidney diseases (ACKD) have 
been described for the first time by Dunnill in 1977  [1] . 
They often result from chronic renal failure or aging, and 
appear frequently in patients who are on long-term dialy-
sis and who have no history of hereditary cystic disease. 
The most severe complication of ACKD is renal cell car-
cinoma, developed by 2–7% of individuals with ACKD 
 Key Words 
Chronic kidney disease · Cell proliferation · PKD1 · PKD2 · 
PKHD1
 Abstract 
 Cystic kidney disease is characterized by the progressive de-
velopment of multiple fluid-filled cysts. Cysts can be ac-
quired, or they may appear during development or in post-
natal life due to specific gene defects and lead to renal fail-
ure. The most frequent form of this disease is the inherited 
polycystic kidney disease (PKD). Experimental models of PKD 
showed that an increase of cellular proliferation and apop-
tosis as well as defects in apico-basal and planar cell polarity 
or cilia play a critical role in cyst development. However, little 
is known about the mechanisms and the mediators involved 
in acquired cystic kidney diseases (ACKD). In this study, we 
used the nephron reduction as a model to study the mecha-
nisms underlying cyst development in ACKD. We found that 
tubular dilations after nephron reduction recapitulated 
most of the morphological features of ACKD. The develop-
ment of tubular dilations was associated with a dramatic in-
crease of cell proliferation. In contrast, the apico-basal polar-
ity and cilia did not seem to be affected. Interestingly, poly-
cystin 1 and fibrocystin were markedly increased and 
polycystin 2 was decreased in cells lining the dilated tubules, 
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 [2] . The mechanisms underlying ACKD are still un-
known.
 The majority of cystic kidney diseases are inherited and 
among them, the most frequent forms are polycystic kid-
ney diseases (PKD). PKD can be inherited either as a dom-
inant or as a recessive trait. The autosomal dominant 
polycystic kidney disease (ADPKD) is the most common 
inherited cystic disease and the most frequent monogenic 
disorder with an estimated incidence between 1: 500 and 
1: 1,000. ADPKD results from mutations in two genes: 
 PKD1 , encoding polycystin-1 (PC1), a large membrane-
associated protein  [3] and  PKD2 , encoding polycystin-2 
(PC2), a calcium channel of the Transient Receptor Po-
tential (TRP) family  [4] . The autosomal recessive polycys-
tic kidney disease (ARPKD) occurs in about 1: 20,000 in-
dividuals and results from mutation in the  PKHD1 gene. 
 PKHD1 encodes for fibrocystin, a large transmembrane 
protein whose function is still unknown  [5] . Despite dif-
ferences in the age of onset, the severity of the disease or 
the localization of the cysts, it has been suggested that 
common mechanisms are involved in cyst formation, in-
cluding cell proliferation and apoptosis  [6] , disturbance of 
cell polarity and cell-matrix interaction  [7] , enhanced flu-
id secretion, or loss of oriented cell division  [8] . On the 
other hand, the primary cilium as well as calcium signal-
ing have been suggested to play a role  [9–12] .
 Interestingly, cysts arising from acquired or hereditary 
diseases appear morphologically similar. In this context, it 
is tempting to speculate that molecules and events in-
volved in inherited PKD might participate in cyst forma-
tion in ACKD. In particular, one could wonder if polycys-
tins play a role in the pathogenesis of ACKD. To test this 
hypothesis, we used the remnant kidney model as a model 
of severe and progressive tubular dilations  [13] to unravel 
the contribution of cystic genes to cystogenesis. We found 
that the expression of PC1 and fibrocystin increased in 
cystic epithelium following nephron reduction, whereas 
that of PC2 was decreased. More importantly, we observed 
that  Pkd1 haploinsufficiency worsens the development of 
tubular dilations and interstitial fibrosis after nephron re-
duction, suggesting that the increase of PC1 in remaining 
nephrons could be linked to a compensatory event.
 Methods 
 Animals 
 Mice used for these studies were FVB/N (Charles River) and 
mutant  Pkd1 +/– mice  [14] .  Pkd1 +/– G1 mice were generated by 
breeding  Pkd1 +/– on a mixed C57BL/6X129/Sv genetic background 
with FVB/N mice. All experiments were performed on 9-week-old 
females, except for  Pkd1 +/–  G1 mice that were studied only in 
9-week-old males. Animals were fed ad libitum and housed at con-
stant ambient temperature in a 12-hour light cycle. Animal proce-
dures were approved by the Departmental Director of ‘Services 
Vétérinaires de la Préfecture de Police de Paris’ and by the ethical 
committee of the Paris Descartes University. 
 Protocol 
 Mice were subjected to 75% nephrectomy (Nx) or sham-opera-
tion (controls), as previously described  [15] . After surgery, mice 
were fed a defined diet containing 30% casein and 0.5% sodium. 
Several groups of mice were investigated in complementary studies. 
For time-course study of nephron reduction model, 6 and 10 FVB/N 
mice for each time point were subjected to either sham-operation or 
Nx, respectively. Mice were sacrificed 30, 42, or 60 days after surgery. 
For transgenic studies, 4–6 mice were subjected to sham-operation 
and 9–11 mice to Nx for both  Pkd1 +/–  G1 and wild-type (WT) lit-
termates. Mice were sacrificed 4 months after surgery and kidneys 
were harvested for morphological, protein, and mRNA studies.
 Human Tissue Samples 
 Kidneys from patients with end-stage renal failure (n = 14;  ta-
ble 1 ), removed at time of transplantation were analyzed for PC1, 
PC2, fibrocystin, and Ki-67 expression. Kidneys not used for trans-
plantation or tumor-free pole of kidneys removed for carcinoma 
were used as controls (n = 7). 
 Morphological Analysis 
 For morphological analysis, kidneys were fixed in 4% parafor-
maldehyde, paraffin embedded, and 4-μm sections were stained 
with PAS, Masson’s trichrome, or Picrosirius Red. The degree of 
tubular, glomerular, and interstitial lesions was evaluated using the 
semiquantitative score methodology as previously described  [16] . 
Briefly, ten to fifteen randomly selected microscopic fields were 
Table 1.  Demographic and clinical characteristics of ACKD patients
Patient Gender Age Pathology
1 M 32 Alport syndrome
2 M 48 Chronic glomerulonephritis
3 M 56 Chronic glomerulonephritis
4 F 61 Chronic interstitial nephritis
5 F 43 Chronic interstitial nephritis
6 M 53 Diabetic nephropathy
7 M 57 Diabetic nephropathy
8 M 49 FSGS
9 F 60 FSGS
10 F 70 FSGS
11 F 40 Hemolytic uremic syndrome
12 M 52 IgA nephropathy
13 F 40 Reflux nephropathy
14 M 25 Renal dysplasia
 FSGS = Focal segmental glomerular sclerosis. All ACKD pa-
tients had end stage renal disease. The age is the age at the time of 
transplantation, when kidney was removed.
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scored using a Nikon digital camera Dx/m/1,200 and Lucia soft-
ware (Laboratory Imaging Ltd.). For tubular lesions, the area of 
tubular lumen was measured on PAS-stained sections and the re-
sults were expressed as a percentage of the total area of the selected 
fields. For interstitial fibrosis, the area covered with red staining 
was quantified on picrosirius-stained sections and the results were 
expressed as a percentage of the total area of the selected fields. The 
degree of glomerular lesions was measured according to a semi-
quantitative method and graded from 0 to 3+ depending on the 
severity of the lesions. 
 Immunohistochemistry 
 Four-μm sections of paraffin-embedded kidneys were incubat-
ed overnight at 4  °  C with biotinylated Lotus Tetragonolobus Lectin 
(Vector), or primary antibodies (sheep anti-Tamm-Horsfall Bio-
genesis), rabbit anti-aquaporin 2 (Sigma), mouse anti-megalin (a 
gift of Pierre Verroust), mouse anti-NaKATPase (Upstate biotech-
nology), mouse anti-acetylated tubulin (Sigma), mouse anti-PC1, 
mouse anti-fibrocystin 1 (kindly provided by Christopher J. 
Ward), rabbit anti-PC2 (kindly provided by Peter Harris), and rab-
bit anti-Ki67 (Novus biological). The sections were then incubated 
with a secondary antibody for 1 h at room temperature and re-
vealed by 3,3 ′ -diaminobenzidine (Dako). The proliferation index 
was calculated as the number of tubular Ki-67-positive nuclei for 
the total number of tubular nuclei.  Ten randomly selected micro-
scopic fields (×400) were scored using a Nikon digital camera 
Dx/m/1200 and Lucia software (Laboratory Imaging Ltd.).
 Real-Time Quantitative PCR 
 Total RNAs were obtained from kidneys using RNeasy Midi kit 
(Qiagen) according to the manufacturer’s protocol. RNAs were re-
verse transcribed (oligo dT primer) according to manufacturer’s pro-
tocols (Invitrogen). Quantitative RT-PCR was carried out using an 
ABI PRISM ® 7700 sequence detection system using SYBR ® Green. 
Primers (Eurogentec) were as follows:  Pkd1 : forward 5 ′ -TTTTA 
AAGTGCAGAAGCCCCA-3 ′ and reverse 5 ′ -GCTGCATGCCA 
GTTCTTTTG-3 ′ ;  Pkd2 : forward 5 ′ -CATGTCTCGATGTGCCA 
AAGA-3 ′ and reverse 5 ′ -ATGGAGAACATTATGGTGAAGCC-3 ′ ; 
 Pkhd1 : forward 5 ′ -AAGTCAAGGGCCATCACATC-3 ′ and reverse 
5 ′ -ATGTTTCTGGTCAACAGCCC-3 ′ ;  Nphp1 : forward 5 ′ -AGAGA 
GGAGAGTTAAGCTGTGGCT-3 ′ and reverse 5 ′ -TGGCATCGAA 
AAGCTTAAGAAAC-3 ′ ;  Nphp2 : forward 5 ′ -ACTTGTTACCCAG 
CATATGTGGTC-3 ′ and reverse 5 ′ -AGGAGAAAACATTTGAAC 
CTTGTCTT-3 ′ ;  Nphp3 : forward 5 ′ -ACAACTCATTCCCCTAAC 
GTTTTT-3 ′ and reverse 5 ′ -TGACGGTTAGCTTTGCCCTT-3 ′ ; 
 Nphp4 : forward 5 ′ -TTGGCAATAAGCCAGAATCTCC-3 ′ and re-
verse 5 ′ -TGATACAGCCTCAACCGTTTGTC-3 ′ ;  Cystin1 : forward 
5 ′ -TCTCGGTTTATGTTGCATCCC-3 ′ and reverse 5 ′ -TGAGGA 
TTCATGGACTGGCA-3 ′ ;  Hnf1b: forward 5 ′ -GTCCAAGCTCA 
CGTCGCTCC-3 ′ and reverse 5 ′- CCAGGTCTTTGCAGAGAA 
CTG C-3 ′ ;  Ift88 : forward 5 ′ -GCAGGCTTCAACCTCATCCTTA-3 ′ 
and reverse 5 ′ -TTTCTCCCGATCTCCAATGG-3 ′ . Gapdh or Rpl13 
were used as the normalization controls.
 Statistical Analysis 
 Data were expressed as means ± SEM. Differences between the 
experimental groups were evaluated using ANOVA, followed 
when significant (p < 0.05) by the Tukey-Kramer test. When only 
two groups were compared, Mann-Whitney tests were used. The 
statistical analysis was performed using Graph Prism Software. 
 Results 
 Nephron Reduction Induces Severe Tubular Dilations 
 We have previously shown that nephron reduction 
(Nx) results in progressive renal lesions in FVB/N ge-
netic background, whereas the C57BL/6 mice undergo 
compensatory growth alone  [13, 17] . In order to inves-
tigate if this model might recapitulate some features of 
ACKD, we characterized the changes of tubular struc-
tures during the evolution of the disease. Two months 
after Nx, we observed that renal lesions were mainly 
represented by severe tubular dilations ( fig. 1 A, inset a), 
which were associated with a marked increase of kidney 
weight (data not shown). Interstitial fibrosis and glo-
merulosclerosis were also observed (online suppl. fig. 1; 
for all online suppl. material, see www.karger.com/
doi/10.1159/000369312). Apical or diffuse accumulation 
of PAS-positive protein droplets of various sizes was ob-
served in enlarged proximal tubular cells ( fig. 1 A, inset 
b). The number and severity of tubular microcystic dila-
tions varied from case to case. They were of several 
types, either lined by hypertrophic and microvacuolat-
ed cells ( fig. 1 A, inset c), or bordered by a flat dediffer-
entiated epithelium ( fig. 1 A, inset d) and/or obstructed 
by large protein casts ( fig. 1 A, inset e). Very focally, cor-
tical tubules, dilated or not, were lined by dark baso-
philic cells (data not shown). Focal tubular necrosis 
with denudation of the tubular basement membrane 
and obstruction of the tubular lumen by cellular debris 
( fig. 1 A, inset f) were also observed. A few atrophic or 
dilated tubules were surrounded by a thick basement 
membrane ( fig. 1 A, inset g). Interestingly, cell exfolia-
tion was observed in tubular lumen ( fig. 1 A, inset h). 
Using specific markers, we showed that tubular dila-
tions developed in all the segments of the nephron, even 
though they predominantly arose from proximal tu-
bules ( fig.  1 B). Quantification confirmed that about 
72% of the cysts were from proximal tubules, 22% from 
Henle’s loop, and only 6% arose from collecting ducts 
( fig. 1 B). 
 Acquired Tubular Dilations Are Associated with 
Normal Cell Polarity, but Increased Proliferation 
 We next tried to elucidate the cellular mechanisms in-
volved in the development of ACKD. To this aim, we first 
focused on events known to induce cyst development in 
inherited cystic diseases. Immunohistochemical analyses 
revealed that, at variance with hereditary cystic disease, 
the apico-basal polarity was preserved after Nx. In fact, 
we observed that megalin, uromodulin (Tamm Horsfall 
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protein), and aquaporin-2 were expressed at the apical 
membrane of proximal tubules, thick ascending limb of 
Henle’s loop and collecting ducts, respectively ( fig. 2 a), 
whereas Na/K ATPase was still expressed at the baso-lat-
eral membrane ( fig.  2 a). Similarly, acetylated tubulin 
staining revealed that the primary cilia were still present 
after Nx ( fig.  2 b) and that their morphology appeared 
normal even in the most dilated tubules ( fig. 2 b). In con-
trast, we observed that tubular cell proliferation was dra-
matically increased after Nx ( fig. 2 c). 
A
a b
c d
e f
g h
Collecting ducts (AQP2)Proximal tubules (LTL) Henle’s loops (TH)
0
20
40
60
80
100
Cy
st
s 
(%
)
PT HL CDB
 Fig. 1. Tubular dilations after nephron reduction recapitulate 
many features of ACKD.  A Morphology of kidneys from 75% ne-
phrectomized (Nx) FVB/N mice visualized by PAS staining, 
2 months after surgery. Insets: ( a ) Tubular lesions, ( b ) Apical ac-
cumulation of PAS-positive protein droplets in proximal tubular 
cells (arrow), ( c ) Dilated tubules with a brush border lined by mi-
crovacuolated cells (arrows), ( d ) Dilated tubules bordered by a flat 
and dedifferentiated epithelium (arrow), ( e ) Dilated tubules ob-
structed by proteinuria (asterisk), ( f ) Dilated tubules obstructed by 
cellular debris (arrow), ( g ) Dilated tubules surrounded by a thick 
basement membrane, ( h ) Cell exofoliation in dilated tubules. Mag-
nification: ×200 ( a ) and ×600 ( b–h ).  B  Localization of microcyst 
dilations  in kidneys from 75% nephrectomized (Nx) FVB/N mice, 
2 months after surgery, by immunohistochemistry (left panels) us-
ing antibodies directed against specific markers of proximal tu-
bules (PT; LTL: Lotus Tetragonolobus Lectin), Henle’s loops (HL; 
TH: Tamm-Horsfall) and collecting ducts (CD; AQP2: Aquaporin 
2), and quantification (right panel) of the percentage nephron seg-
ments depicting tubular dilations. Magnification: ×200. Pictures 
are representative samples from 10 Nx mice. 
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 Cystic Genes Expression Is Altered in Acquired Cyst 
Formation 
 Then, we wondered if the expression of genes involved 
in hereditary PKD was modified after Nx. Real-time quan-
titative RT-PCR revealed that the expression of  Pkd1 and 
 Pkhd1 was  significantly increased, while that of  Pkd2 was 
decreased 2 months after Nx ( fig. 3 a). We also  analyzed 
the expression of other genes known to be involved in cys-
tic diseases:  Nphp1, 2, 3  and  4,  Cystin 1, Hnf1b,  and Ift88. 
Interestingly, over the seven genes studied, only  Nphp2 
b 
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 Fig. 2. Cell proliferation, but not dedifferentiation, is associated 
with tubular dilations after nephron reduction.  a Megalin, Tamm-
Horsfall, Aquaporin 2, and Na/K ATPase expression evaluated by 
immunohistochemistry in sham-operated (Control) and 75% ne-
phrectomized (Nx) FVB/N mice, 2 months after surgery. Magni-
fication: ×600.  b  Primary cilium visualized by immunofluores-
cence using anti-acetylated tubulin antibodies, 2 months after 
nephron reduction. Primary cilia (green) are still present and mor-
phologically normal after nephron reduction, even in the most di-
lated tubules (cyst). Magnification: ×1,000.  c Ki-67 staining and 
quantification of tubular cell proliferation in kidneys from control 
and Nx FVB/N mice, 2 months after surgery. Magnification: ×200. 
Data are means ± SEM; n = 4–6 and 6–10 for control and Nx mice, 
respectively. Mann-Whitney test; control versus Nx mice:  *  p < 
0.05. 
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was slightly decreased after Nx (online suppl. fig. 2), sug-
gesting a specific regulation of cystic genes during ACKD.
 Immunohistochemistry revealed that the expression 
of PC1 and fibrocystin was almost undetectable in sham-
operated mice, whereas PC2 was very highly expressed 
( fig.  3 b). Interestingly, the expression pattern was re-
versed after Nx. In fact, while PC1 and fibrocystin were 
markedly increased, PC2 was significantly decreased 
in  cells lining the dilated tubules of remnant kidneys 
2 months after Nx. Both PC1 and fibrocystin were main-
ly expressed at the apical membrane of dilated tubules 
( fig. 3 b). In addition, while PC2 expression was turned off 
in cyst-lining cells, it was still maintained in the few non-
dilated tubules of damaged kidneys. 
 Pkd1 Haploinsufficiency Increases Susceptibility to 
Renal Damage Following Nephron Reduction 
 To assess the contribution of cystic genes to ACKD, 
we examined the impact of Nx in  Pkd1 +/– mice  [14] . As 
 Pkd1 +/– mice were on a mixed genetic background 
(C57BL/6x129/Sv) that we previously showed to be resis-
tant to Nx  [13, 18] , we crossed these mice with the FVB/N 
lesion-prone mice in order to generate a more sensitive 
strain. In fact, we previously showed that F1 males origi-
nated from C57BL/6XFVB/N crosses are sensitive to Nx. 
In sham-operated mice, we observed no gross differenc-
es of renal morphology between  Pkd1 +/+  and  Pkd1 +/– 
mice (data not shown). As expected, after Nx, wild-type 
mice developed renal lesions, although less severe than 
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 Fig. 3. Cystic disease gene expression is modified after nephron 
reduction.  a ,  b Polycystin 1 (PC1), fibrocystin and polycystin 2 
(PC2) expression evaluated by ( a ) real-time RT-PCR and ( b ) im-
munohistochemistry in kidneys from sham-operated (C, Control) 
and 75% nephrectomized (Nx) FVB/N mice, 2 months after sur-
gery. Pictures are representative samples from at least 6 mice from 
each group. ×400. Data are means ± SEM; n = 6 and 6–10 for con-
trol and Nx mice, respectively. Mann-Whitney test; control  versus 
 Nx mice:  *  p < 0.05,  * *  p < 0.01. 
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those observed in the pure FVB/N genetic background 
( fig. 4 a). The renal lesions were scattered and included 
tubular dilations and interstitial fibrosis, but no glomer-
ular lesions. Interestingly, the frequency and severity of 
renal lesions were increased in mice lacking PC1 ( fig. 4 a). 
Quantification revealed that  Pkd1 +/– mice had signifi-
cantly higher scores of tubular, glomerular, and intersti-
tial damages compared to  Pkd1 +/+ littermates ( fig. 4 b). 
Consistent with these findings, kidney weight was sig-
nificantly higher in  Pkd1 +/– mice than in  Pkd1 +/+ litter-
mates (online suppl. fig. 3). Immunohistochemistry re-
vealed that tubular dilations originated predominantly 
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 Fig. 4.  Pkd1 haploinsufficiency worsens renal lesions after nephron 
reduction.  a  Morphology of kidneys from control (upper panels) 
and 75% nephrectomized (Nx)  Pkd1 +/+ (middle panels) and 
 Pkd1 +/– (lower panels) mice, 4 months after surgery. Magnifica-
tion: ×200, ×200, ×400 for tubular, interstitial and glomerular le-
sions, respectively. Because no differences were detected between 
wild-type and mutant control mice, only one group is shown. 
 b  Quantification of the kidney lesions in the different experimen-
tal groups. Data are means ± SEM; n = 3 and 6 for each control and 
Nx mice, respectively. ANOVA followed by Tukey-Kramer test; 
control  versus Nx:  *  p < 0.05,  * * *  p < 0.001. 
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from proximal tubules, even though they were found in 
all the segments of the nephron ( fig. 5 a). Interestingly, 
tubular cell proliferation was much higher after Nx in 
kidneys of  Pkd1 +/– mice as compared to  Pkd1 +/+ litter-
mates ( fig. 5 b). Of note,  Pkd1 haploinsufficiency did not 
induce any prompt tubular cell proliferation in control 
sham-operated mice.
 Cystic Genes Expression and Cell Proliferation Are 
Modified in Human ACKD 
 Finally, we investigated if these finding were relevant 
to human ACKD. Immunohistochemistry showed a 
strong increase of PC1, fibrocystin, and PC2 expression 
in cystic kidneys from patients with end-stage renal dis-
ease as compared to controls ( fig. 6 a). A careful analysis 
revealed that these proteins were overexpressed specifi-
cally in cysts, but not in controls. Interestingly, tubular 
cell proliferation was also markedly increased in cystic 
human kidneys as compared to control kidneys ( fig. 6 b).
 Discussion 
 The mechanisms underlying ACKD are still unknown, 
notably because there is no animal model able to recapitu-
late this pathology. In this study, we took advantage of an 
experimental model (subtotal nephrectomy) that we pre-
viously showed to induce severe tubular dilations when 
applied to FVB/N mice to show that the mechanisms in-
volved in inherited PKD might also play a role in ACKD. 
In particular, we observed that an increase of cell prolif-
eration as well as an imbalance among cystic genes expres-
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Nx Pkd1+/–Nx Pkd1+/+Control Pkd1+/+
Pr
ol
ife
ra
tio
n 
in
de
x 
(%
)
1
5
4
3
2
**
0
a
b 
0
20
40
60
80
100
PT HL CD
Cy
st
s 
(%
)
Control Nx Pkd1+/–Nx Pkd1+/+
 Fig. 5.  Pkd1 haploinsufficiency results in increased tubular prolif-
eration in Pkd1 +/– mice after nephron reduction.  a Immunohisto-
chemistry (left panels) using antibodies directed against specific 
markers of proximal tubules (LTL: Lotus Tetragonolobus Lectin), 
Henle’s loops (TH: Tamm-Horsfall) and collecting ducts (AQP2: 
Aquaporin 2), and quantification (right panel) of the percentage 
of nephron segments depicting tubular dilations. Magnification: 
×200.  b Ki-67 staining (left panels) and quantification (right pan-
el) of tubular proliferation in kidneys from control and 75% ne-
phrectomized (Nx)  Pkd1 +/+ and  Pkd1 +/– mice, 4 months after sur-
gery. Because no differences were detected between wild-type and 
mutant control mice, only one group is shown. Magnification: 
×200. Data are means ± SEM; n = 3 and 6 for each control and Nx 
mice, respectively. ANOVA followed by Tukey-Kramer test; con-
trol versus Nx mice:  * *  p < 0.01. 
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sion accompanied the development of tubular dilations 
after nephron reduction. Interestingly,  Pkd1  haploinsuf-
ficiency lead to increased tubular dilations and higher pro-
liferation following nephron reduction. These results were 
relevant to human ACKD, as cystic genes and proliferation 
were also increased in cystic kidneys. It is worth noting 
that our experimental model reproduced most of the mor-
phological changes previously reported in human ACKD: 
cysts that arose mainly from proximal tubules were sur-
rounded by a flat epithelium and were hyperproliferative 
 [19, 20] . Taken together, these results showed that cystic 
genes are critically involved in ACKD and uncovered a 
novel model for elucidating the pathophysiology of ACKD. 
 An increasing number of evidence supports the idea of 
a gene-dosage-dependent mechanism for ADPKD where 
mutations of loss of heterozygosity, haploinsufficiency, 
or even an overexpression could lead a cystic phenotype 
 [21] . In the present study, we found that the development 
of tubular dilations following nephron reduction is asso-
ciated with a particular pattern of cystic gene expression. 
In fact, if most of the genes were not affected, the expres-
sion of PC1 and fibrocystin were selectively increased in 
cystic-lining cells, whereas that of PC2 was decreased. In-
terestingly, PC1 expression has been found selectively in-
creased even in cysts of both humans and experimental 
models of ADPKD  [22–24] , suggesting that an imbalance 
or deregulation of PC1 is sufficient to prompt cyst devel-
opment. Since PC1 and PC2 have been shown to act in 
the same molecular complex, it is likely that the stoichi-
ometry of the two proteins is essential for their function. 
 The observation that, despite the dramatic increase of 
PC1 in dilated tubules,  Pkd1  haploinsufficiency worsened 
the progression of the disease following nephron reduc-
tion is quite interesting. In fact, from results obtained in 
transgenic mice overexpressing  Pkd1  [22] , one could ex-
pect that  PC1 overexpression participates to lesion devel-
opment. However, we observed that  Pkd1 inactivation in-
creased both tubular cell proliferation and tubular dila-
tions. Hence, it is tempting to speculate that PC1 
overexpression could rather act as a compensatory path-
way activated in order to counteract critical events of the 
cystogenic process, that is, cell proliferation. In favor of 
this hypothesis, a recent study suggested that PC1 and 
PC2 may act by inhibiting a cilia-dependent cyst growth-
promoting pathway  [25] . Disruption of cilia in a context 
of adult-onset ADPKD reduces cyst growth in comple-
mentary models of transgenic mice  [25] . In this context, 
the rate of cell proliferation is higher in cilia devoid of 
polycystins. Consistent with these results, we have ob-
served that the morphological appearance of cilia ap-
peared normal in our model and that cell proliferation 
was increased in tubules of  Pkd1 +/–  mice following neph-
ron reduction. 
 It has been suggested that, in inherited PKD, the trans-
location of transporters from the basal to the apical mem-
brane may participate to cysts enlargement through an 
increase of fluid secretion  [7, 26] . In the present study, we 
failed to detect any change of the apico-basal polarity in 
a
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 Fig. 6. Cystic disease genes expression and tubular cell prolifera-
tion in human ACKD.  a  Polycystin 1 (PC1), fibrocystin and poly-
cystin 2 (PC2) protein expression evaluated by immunohisto-
chemistry in kidneys from controls and ACKD patients. Magnifi-
cation: ×400.  b Ki-67 staining of tubular cell proliferation in 
kidneys from controls and cystic patients. Magnification: ×200. 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
5/
26
/2
01
6 
4:
01
:5
6 
PM
 Cystic Gene Balance and Chronic Kidney 
Disease Progression 
Nephron 2015;129:42–51
DOI: 10.1159/000369312
51
 References 
 1 Dunnill MS, Millard PR, Oliver D: Acquired 
cystic disease of the kidneys: a hazard of long-
term intermittent maintenance haemodialy-
sis. J Clin Pathol 1977; 30: 868–877. 
 2 Matson MA, Cohen EP: Acquired cystic kid-
ney disease: occurrence, prevalence, and renal 
cancers. Medicine (Baltimore) 1990; 69: 217–
226. 
 3 Hughes J, et al: The polycystic kidney disease 
1 (PKD1) gene encodes a novel protein with 
multiple cell recognition domains. Nat Genet 
1995; 10: 151–160. 
 4 Qamar S, Vadivelu M, Sandford R: TRP chan-
nels and kidney disease: lessons from polycys-
tic kidney disease. Biochem Soc Trans 2007; 
 35: 124–128. 
 5 Nagasawa Y, et al: Identification and charac-
terization of Pkhd1, the mouse orthologue of 
the human ARPKD gene. J Am Soc Nephrol 
2002; 13: 2246–2258. 
 6 Torres VE, Harris PC: Strategies targeting 
cAMP signaling in the treatment of polycystic 
kidney disease. J Am Soc Nephrol 2014; 25: 
 18–32. 
 7 Stoops EH, Caplan MJ: Trafficking to the api-
cal and basolateral membranes in polarized 
epithelial cells. J Am Soc Nephrol 2014; 25: 
 1375–1386. 
 8 Verdeguer F, et al: A mitotic transcriptional 
switch in polycystic kidney disease. Nat Med 
2010; 16: 106–110. 
 9 Jonassen JA, et al: Deletion of IFT20 in the 
mouse kidney causes misorientation of the 
mitotic spindle and cystic kidney disease. J 
Cell Biol 2008; 183: 377–384. 
 10 Patel V, et al: Acute kidney injury and aber-
rant planar cell polarity induce cyst formation 
in mice lacking renal cilia. Hum Mol Genet 
2008; 17: 1578–1590. 
 11 Davenport JR, et al: Disruption of intraflagel-
lar transport in adult mice leads to obesity and 
slow-onset cystic kidney disease. Curr Biol 
2007; 17: 1586–1594. 
 12 Lin F, et al: Kidney-specific inactivation of the 
KIF3A subunit of kinesin-II inhibits renal cilio-
genesis and produces polycystic kidney disease. 
Proc Natl Acad Sci U S A 2003; 100: 5286–5291. 
 13 Pillebout E, et al: Proliferation and remodel-
ing of the peritubular microcirculation after 
nephron reduction: association with the pro-
gression of renal lesions. Am J Pathol 2001; 
 159: 547–560. 
 14 Muto S, et al: Pioglitazone improves the phe-
notype and molecular defects of a targeted 
Pkd1 mutant. Hum Mol Genet 2002; 11: 1731–
1742. 
 15 Terzi F, et al: Reduction of renal mass is lethal 
in mice lacking vimentin. Role of endothelin-
nitric oxide imbalance. J Clin Invest 1997; 100: 
 1520–1528. 
 16 Pillebout E, et al: JunD protects against chron-
ic kidney disease by regulating paracrine mi-
togens. J Clin Invest 2003; 112: 843–852. 
 17 Laouari D, et al: TGF-alpha mediates genetic 
susceptibility to chronic kidney disease. J Am 
Soc Nephrol 2011; 22: 327–335. 
 18 Laouari D, et al: A transcriptional network 
underlies susceptibility to kidney disease pro-
gression. EMBO Mol Med 2012; 4: 825–839.  
 19 Vandeursen H, et al: Acquired cystic disease 
of the kidney analyzed by microdissection. J 
Urol 1991; 146: 1168–1172. 
 20 Costa MZ, Bacchi CE, Franco M: Histogene-
sis of the acquired cystic kidney disease: an 
immunohistochemical study. Appl Immuno-
histochem Mol Morphol 2006; 14: 348–352. 
 21 Fedeles SV, Gallagher AR, Somlo S: Polycys-
tin-1: a master regulator of intersecting cystic 
pathways. Trends Mol Med 2014; 20: 251–
260. 
 22 Thivierge C, et al: Overexpression of PKD1 
causes polycystic kidney disease. Mol Cell 
Biol 2006; 26: 1538–1548. 
 23 Burtey S, et al: Overexpression of PKD2 in the 
mouse is associated with renal tubulopathy. 
Nephrol Dial Transplant 2008; 23: 1157–1165. 
 24 Kurbegovic A, et al: Pkd1 transgenic mice: 
adult model of polycystic kidney disease with 
extrarenal and renal phenotypes. Hum Mol 
Genet 2010; 19: 1174–1189. 
 25 Ma M, et al: Loss of cilia suppresses cyst 
growth in genetic models of autosomal domi-
nant polycystic kidney disease. Nat Genet 
2013; 45: 1004–1012. 
 26 Wilson PD, et al: Apical plasma membrane 
mispolarization of NaK-ATPase in polycystic 
kidney disease epithelia is associated with ab-
errant expression of the beta2 isoform. Am J 
Pathol 2000; 156: 253–268. 
 27 Brill SR, et al: Immunolocalization of ion 
transport proteins in human autosomal dom-
inant polycystic kidney epithelial cells. Proc 
Natl Acad Sci U S A 1996; 93: 10206–10211. 
 28 Terryn S, et al: Fluid transport and cystogen-
esis in autosomal dominant polycystic kidney 
disease. Biochim Biophys Acta 2011; 1812: 
 1314–1321. 
cells lining tubular dilations. It is possible that this mech-
anism is not involved in ACKD. Alternatively, we cannot 
exclude that at a later stage, fluid secretion might be crit-
ically involved in cyst enlargement. Moreover, we cannot 
argue against the possibility that the location of other 
transporters known to be involved in the transepithelial 
secretion of chloride in PKD might be affected  [27, 28] . 
 In conclusion, our study revealed that the mechanisms 
involved in cyst formation in heredity PKD, that is, cell 
proliferation and cystic gene-dosage, may also play a role 
in ACKD. In this context, PC1 may act by inhibiting cell 
proliferation. Together these results indicate that the huge 
efforts made to develop new therapies for PKD might be 
beneficial for all those patients who develop cysts in post-
natal life, including patients with chronic kidney disease. 
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